|
Volumn 99, Issue 6, 2014, Pages 837-838
|
Hypoxic pulmonary hypertension: The paradigm is changing
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MYOSIN LIGHT CHAIN;
MYOSIN LIGHT CHAIN PHOSPHATASE;
RHO KINASE;
CALCIUM CHANNEL L TYPE;
CALCIUM CHANNEL T TYPE;
PROTEIN SERINE THREONINE KINASE;
VASOCONSTRICTOR AGENT;
ACTIN MYOSIN INTERACTION;
ALTITUDE;
ARTICLE;
BLOOD VESSEL TONE;
BLOOD VESSEL WALL;
CHRONIC LUNG DISEASE;
DISABILITY;
HUMAN;
HYPOTENSION;
HYPOXIA;
HYPOXIC LUNG VASOCONSTRICTION;
LIFE EXPECTANCY;
LUNG BLOOD VESSEL;
LUNG CIRCULATION;
LUNG VASCULAR RESISTANCE;
MIGRATION;
NONHUMAN;
PROTEIN PHOSPHORYLATION;
PULMONARY HYPERTENSION;
SMOOTH MUSCLE CONTRACTILITY;
SMOOTH MUSCLE CONTRACTION;
VASODILATATION;
ANIMAL;
ANOXIA;
ANTAGONISTS AND INHIBITORS;
BIOSYNTHESIS;
DRUG EFFECTS;
GENE EXPRESSION REGULATION;
HYPERTENSION, PULMONARY;
MALE;
METABOLISM;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
PULMONARY ARTERY;
VASOCONSTRICTION;
ANIMALS;
ANOXIA;
CALCIUM CHANNELS, L-TYPE;
CALCIUM CHANNELS, T-TYPE;
GENE EXPRESSION REGULATION;
HYPERTENSION, PULMONARY;
MALE;
PROTEIN-SERINE-THREONINE KINASES;
PULMONARY ARTERY;
PULMONARY CIRCULATION;
VASOCONSTRICTION;
VASOCONSTRICTOR AGENTS;
|
EID: 84901489124
PISSN: 09580670
EISSN: 1469445X
Source Type: Journal
DOI: 10.1113/expphysiol.2014.078485 Document Type: Article |
Times cited : (5)
|
References (5)
|